Literature DB >> 18042794

Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.

Becky M Vonakis1, Donald W Macglashan, Natalia Vilariño, Jacqueline M Langdon, Rebecca S Scott, Susan M MacDonald.   

Abstract

We previously identified a negative correlation between histamine release to histamine releasing factor/translationally controlled tumor protein (HRF/TCTP) and protein levels of the Src homology 2 domain-containing inositol 5' phosphatase (SHIP) in basophils. We have also demonstrated that HRF/TCTP primes basophils to release mediators. The purpose of this study was to begin characterization of signal transduction events directly induced by HRF/TCTP and to investigate these events when HRF/TCTP is used as a priming agent for human basophil histamine release. Highly purified human basophils were examined for surface expression of bound HRF/TCTP, changes in calcium, and phosphorylation of Akt, mitogen-activated protein kinase kinase (MEK), extracellular signal-regulated kinase (ERK), Syk, and FcepsilonRIgamma. Results showed that basophils from all donors bound HRF/TCTP. There was a biphasic calcium response to HRF/TCTP, which corresponded to the magnitude of histamine release. Furthermore, those donors who have direct histamine release when exposed to HRF/TCTP (HRF/TCTP responder [HRF/TCTP-R] donors) have phosphorylation of Syk, Akt, MEK, and ERK. Remarkably, basophils from HRF/TCTP-nonresponder (HRF/TCTP-NR) donors do not show phosphorylation of these molecules. This finding is different from IL-3, which also primes basophils for histamine release, but does show phosphorylation of these events. We conclude that priming induced by HRF/TCTP is distinct from that induced by IL-3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042794      PMCID: PMC2234039          DOI: 10.1182/blood-2007-07-104364

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.

Authors:  S S Saini; D W MacGlashan; S A Sterbinsky; A Togias; D C Adelman; L M Lichtenstein; B S Bochner
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Refinements in the automated fluorometric histamine analysis system.

Authors:  R P Siraganian
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

3.  Acute IL-3 priming up-regulates the stimulus-induced Raf-1-Mek-Erk cascade independently of IL-3-induced activation of Erk.

Authors:  Natalia Vilariño; Katsushi Miura; Donald W MacGlashan
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Nonspecific desensitization, functional memory, and the characteristics of SHIP phosphorylation following IgE-mediated stimulation of human basophils.

Authors:  Donald MacGlashan; Natalia Vilariño
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.

Authors:  K Miura; J T Schroeder; W C Hubbard; D W MacGlashan
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

6.  Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor.

Authors:  R Bheekha-Escura; S R Chance; J M Langdon; D W MacGlashan; S M MacDonald
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

7.  Stimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factor.

Authors:  Kazuo Yoneda; Kazuhito Rokutan; Yoichi Nakamura; Hiroaki Yanagawa; Shigetada Kondo-Teshima; Saburo Sone
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-29       Impact factor: 5.464

8.  Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action.

Authors:  R P Schleimer; D W MacGlashan; E Gillespie; L M Lichtenstein
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Phosphorylation of cytosolic phospholipase A2 by IL-3 is associated with increased free arachidonic acid generation and leukotriene C4 release in human basophils.

Authors:  K Miura; W C Hubbard; D W MacGlashan
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

10.  Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta).

Authors:  Jacqueline M Langdon; Becky M Vonakis; Susan M MacDonald
Journal:  Biochim Biophys Acta       Date:  2004-04-05
View more
  15 in total

Review 1.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

2.  Overexpression of Arabidopsis translationally controlled tumor protein gene AtTCTP enhances drought tolerance with rapid ABA-induced stomatal closure.

Authors:  Yong-Min Kim; Yun-Jeong Han; Ok-Jin Hwang; Si-Seok Lee; Ah-Young Shin; Soo Young Kim; Jeong-Il Kim
Journal:  Mol Cells       Date:  2012-05-17       Impact factor: 5.034

3.  Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication.

Authors:  I Sirois; M-A Raymond; N Brassard; J-F Cailhier; M Fedjaev; K Hamelin; I Londono; M Bendayan; A V Pshezhetsky; M-J Hébert
Journal:  Cell Death Differ       Date:  2010-10-22       Impact factor: 15.828

4.  Enhanced basophil reactivities during severe malaria and their relationship with the Plasmodium falciparum histamine-releasing factor translationally controlled tumor protein.

Authors:  Stéphane Pelleau; Sylvie Diop; Méry Dia Badiane; Joana Vitte; Pierre Beguin; Farida Nato; Bernard M Diop; Pierre Bongrand; Daniel Parzy; Ronan Jambou
Journal:  Infect Immun       Date:  2012-07-02       Impact factor: 3.441

5.  Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent.

Authors:  Jianfeng Dai; Sukanya Narasimhan; Lili Zhang; Lei Liu; Penghua Wang; Erol Fikrig
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

6.  Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models.

Authors:  Jacqueline M Langdon; John T Schroeder; Becky M Vonakis; Anja P Bieneman; Kristin Chichester; Susan M Macdonald
Journal:  J Leukoc Biol       Date:  2008-07-14       Impact factor: 4.962

7.  Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.

Authors:  Susan M Macdonald
Journal:  J Asthma Allergy       Date:  2012-09-17

8.  Dimerization of translationally controlled tumor protein is essential for its cytokine-like activity.

Authors:  Miyoung Kim; Hyun Jung Min; Hee Yeon Won; Heejin Park; Ji-Chul Lee; Heung-Woo Park; Junho Chung; Eun Sook Hwang; Kyunglim Lee
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

9.  Translationally controlled tumor protein, a dual functional protein involved in the immune response of the silkworm, Bombyx mori.

Authors:  Fei Wang; Cuimei Hu; Xiaoting Hua; Liang Song; Qingyou Xia
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

10.  TCTP is an androgen-regulated gene implicated in prostate cancer.

Authors:  Mari Kaarbø; Margrethe L Storm; Su Qu; Håkon Wæhre; Bjørn Risberg; Håvard E Danielsen; Fahri Saatcioglu
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.